Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Aug. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigat... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Aug. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More


Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, Aug. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More


Clinical Trial: A Case of Multiple Endocrine Neoplasia Type 1 (China)

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Case of Multiple Endocrine Neoplasia Type 1'. The following are the other relevant de... Read More


Clinical Trial: A comparative study of plastic and Metal stents for Endoscopic ultrasound-guided hepaticogastrostomy: A prospective multicenter randomized controlled trial (China)

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A comparative study of plastic and Metal stents for Endoscopic ultrasound-guided hepati... Read More


Clinical Trial: The Effects of Second-Generation Antipsychotic Drugs on Human Body Composition and Energy Metabolism (China)

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Effects of Second-Generation Antipsychotic Drugs on Human Body Composition and Ener... Read More


Clinical Trial: Analysis of the Effect of Rapid Recovery Surgical Care in the Perioperative Period of Elderly Fracture Internal Fixation Surgery (China)

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of the Effect of Rapid Recovery Surgical Care in the Perioperative Period of E... Read More


Clinical Trial: Study on the correlation between stigma and health information seeking behavior of type 2 diabetes in rural elderly (China)

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the correlation between stigma and health information seeking behavior of type... Read More


Clinical Trial: An open, multicenter Phase I clinical study on the safety, efficacy and pharmacokinetics of SH006 injection in patients with advanced solid tumors (China)

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An open, multicenter Phase I clinical study on the safety, efficacy and pharmacokinetic... Read More